Search Results 31-40 of 16242 for what is vedolizumab

  1. Inflammatory bowel disease (IBD) - Symptoms and causes - Mayo Clinic

    Ulcerative colitis. This condition involves inflammation and sores (ulcers) along the lining of your large intestine (colon) and rectum. · Crohn's disease.

  2. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis · Overview · Participation ...

  3. Infliximab-Axxq (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab-axxq injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who ...

  4. A Study to Evaluate the Effectiveness and Safety of Vedolizumab to Treat Chronic Pouchitis - Mayo Clinic

    The purpose of this study is to assess the efficacy and safety of vedolizumab intravenous (IV) in participants with a proctocolectomy and ileal pouch anal ...

  5. Mayo Clinic Minute: What is inflammatory bowel disease?

    "Ulcerative colitis only impacts the colon and causes inflammation in the entire colon, while Crohn's disease can impact anywhere from the mouth to the anus," ...

  6. Adalimumab-Adaz (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Adalimumab-adaz injection is also used to treat moderate to severe active Crohn's disease. It is also used to treat moderate to severe ulcerative colitis in ...

  7. Balsalazide (Oral Route) Description and Brand Names - Mayo Clinic

    Balsalazide is used to treat an inflammatory bowel disease called ulcerative colitis. Balsalazide capsules are used to treat mild to moderately active ...

  8. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    The Food and Drug Administration (FDA) recently expanded the approval of tofacitinib to include adults with moderately to severely active ulcerative colitis ...

  9. Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of vedolizumab when added to background aGvHD prophylaxis regimen compared to placebo and background ...

  10. Infliximab-Qbtx (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab-qbtx injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...